O'Shares Investment Advisers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
O'Shares Investment Advisers's MDT Position: Q2 2022 in Review
O'Shares Investment Advisers sold out of Medtronic (MDT) in Q2 2022, closing a stake of 44,098 shares — an estimated $4.89M sold.
O'Shares Investment Advisers first reported a position in MDT in Q4 2018 and held it in 14 quarters. The position peaked at $7.41M in Q2 2021. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.
- O'Shares Investment Advisers reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
- O'Shares Investment Advisers sold 44,098 Medtronic shares in Q2 2022, an estimated $4.89M.
- O'Shares Investment Advisers first reported a position in Medtronic in Q4 2018 and held it in 14 quarters.
- O'Shares Investment Advisers's Medtronic position peaked at $7.41M in Q2 2021.
- 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.
Based on O'Shares Investment Advisers's 13F filing for Q2 2022.